Tags
- 1L
- A
- ACCE
- ADC
- Advanced
- All Right
- Analyse
- Analysis
- Annals of Oncology
- Application
- Ascó
- Avelumab
- Bladder
- Bladder cancer
- Breakthrough
- Breakthrough therapy
- Cancer
- Carcinoma
- Care
- Chemotherapy
- Chemotherapy regimen
- CLIN
- Clinical
- Clinical Practice
- Defined
- Designation
- Diagnosis
- EAP
- ESMO
- E.T.
- Expanded access
- Expansion
- FDA
- Follow-up
- Food and Drug Administration
- Frontier
- Frontiers
- Frontiers Media
- Guideline
- H
- Hangul
- J
- Janggi
- Javelin
- Journal of Clinical Oncology
- Korean
- Landscape
- Local property
- Long term
- Long-term follow-up
- Maintenance
- Maintenance therapy
- Medical guideline
- Merck
- Metástasis
- NCCN
- New
- Oncology
- Oncol Park
- Package insert
- Paradigm
- Paradigm shift
- Park
- Patient
- PD-L1
- Pfizer
- Poster
- Powle
- Powles
- Prescription
- Press release
- Real World
- Regimen
- Reinforcement
- Result
- Rights
- Shift
- Slide
- Standard of care
- Start
- Subgroup
- Submit
- Survival
- Survival rate
- Therapy
- Transitional cell carcinoma
- Trial
- Urothelium
- Yi Sang
- Yonsei University